Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paw Jensen

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Case Reports in Hematology|September 1, 2012
Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the LiteratureAnders Kindberg Boysen, Paw Jensen, Preben Johansen, et al.
British Journal of Haematology|March 2, 2022
Bone health and glucocorticoid-containing lymphoma therapy - a review of risk factors and preventative measuresToby A Eyre, Paw Jensen, Stephen Booth, et al.
Clinical Case Reports|March 14, 2018
Fatal cardiac arrhythmia caused by tumor lysis in a patient with diffuse large B-cell lymphoma upon start of R-CHOPNina Sørensen, Paw Jensen, Erik Clasen-Linde, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2019
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic reviewMarie Lindhard Madsen, Hanne Due, Niels Ejskjær, et al.
Ugeskrift for Laeger|August 1, 2020
[Fever, loss of vision and acute promyelocytic leukemia at the pandemic ward]Daniel Kristensen, Søren Niemi Helsø, Paw Jensen, et al.
British Journal of Haematology|August 24, 2006
Fracture risk in patients with monoclonal gammopathy of undetermined significanceHenrik Gregersen, Paw Jensen, Mette Gislum, et al.
Journal of Cancer Survivorship : Research and Practice|January 6, 2021
Hematological cancer survivors' experiences of participating in a shared care follow-up-an exploratory interview studyMia Sommer, Lone Frandsen, Paw Jensen, et al.
European Journal of Haematology|October 15, 2010
Monoclonal gammopathy of undetermined significance and risk of venous thromboembolismHenrik Gregersen, Mette Nørgaard, Marianne T Severinsen, et al.
European Journal of Internal Medicine|November 30, 2010
Survival of cancer patients with prior monoclonal gammopathy of undetermined significanceHenrik Gregersen, Henrik Toft Sørensen, Malene Cramer Engebjerg, et al.
Blood Advances|January 19, 2022
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatmentPaw Jensen, Lasse Hjort Jakobsen, Martin Bøgsted, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Case Reports in Hematology|September 1, 2012
Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the LiteratureAnders Kindberg Boysen, Paw Jensen, Preben Johansen, et al.
British Journal of Haematology|March 2, 2022
Bone health and glucocorticoid-containing lymphoma therapy - a review of risk factors and preventative measuresToby A Eyre, Paw Jensen, Stephen Booth, et al.
Clinical Case Reports|March 14, 2018
Fatal cardiac arrhythmia caused by tumor lysis in a patient with diffuse large B-cell lymphoma upon start of R-CHOPNina Sørensen, Paw Jensen, Erik Clasen-Linde, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2019
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic reviewMarie Lindhard Madsen, Hanne Due, Niels Ejskjær, et al.
Ugeskrift for Laeger|August 1, 2020
[Fever, loss of vision and acute promyelocytic leukemia at the pandemic ward]Daniel Kristensen, Søren Niemi Helsø, Paw Jensen, et al.
British Journal of Haematology|August 24, 2006
Fracture risk in patients with monoclonal gammopathy of undetermined significanceHenrik Gregersen, Paw Jensen, Mette Gislum, et al.
Journal of Cancer Survivorship : Research and Practice|January 6, 2021
Hematological cancer survivors' experiences of participating in a shared care follow-up-an exploratory interview studyMia Sommer, Lone Frandsen, Paw Jensen, et al.
European Journal of Haematology|October 15, 2010
Monoclonal gammopathy of undetermined significance and risk of venous thromboembolismHenrik Gregersen, Mette Nørgaard, Marianne T Severinsen, et al.
European Journal of Internal Medicine|November 30, 2010
Survival of cancer patients with prior monoclonal gammopathy of undetermined significanceHenrik Gregersen, Henrik Toft Sørensen, Malene Cramer Engebjerg, et al.
Blood Advances|January 19, 2022
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatmentPaw Jensen, Lasse Hjort Jakobsen, Martin Bøgsted, et al.
Pageof 4